As stem cell industry explodes, can a static FDA keep up?
There are legitimate arguments about the degree to which the FDA should regulate stem cell clinics and the point-of-care, for-profit stem cell industry. I’ve held debates about that on my blog with argument on both sides including a very valuable debate between Dr. Chris Centeno and Doug Sipp. However, increasingly it is looking like the […]
As stem cell industry explodes, can a static FDA keep up? Read More »